356 related articles for article (PubMed ID: 34323298)
1. Emerging cases of mucormycosis under COVID-19 pandemic in India: Misuse of antibiotics.
Gupta G; S R; Singh Y; Thangavelu L; Singh SK; Dureja H; Chellappan DK; Dua K
Drug Dev Res; 2021 Nov; 82(7):880-882. PubMed ID: 34323298
[TBL] [Abstract][Full Text] [Related]
2. The "Black Fungus" in India: The Emerging Syndemic of COVID-19-Associated Mucormycosis.
Gandra S; Ram S; Levitz SM
Ann Intern Med; 2021 Sep; 174(9):1301-1302. PubMed ID: 34097436
[TBL] [Abstract][Full Text] [Related]
3. Mucormycosis, past and present: a comprehensive review.
Gupta I; Baranwal P; Singh G; Gupta V
Future Microbiol; 2023 Feb; 18():217-234. PubMed ID: 36970978
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 associated mucormycosis - An emerging threat.
Chao CM; Lai CC; Yu WL
J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
[TBL] [Abstract][Full Text] [Related]
6. Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications.
Gurunathan S; Lee AR; Kim JH
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293381
[TBL] [Abstract][Full Text] [Related]
7. Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic.
Gambhir RS; Aggarwal A; Bhardwaj A; Kaur A; Sohi RK; Mehta S
Rocz Panstw Zakl Hig; 2021; 72(3):239-244. PubMed ID: 34553877
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, Risk Factors, Diagnosis and Treatment of Mucormycosis (Black Fungus): A Review.
Upadhayay P; Bansal K; Goyal A
Curr Pharm Biotechnol; 2023; 24(13):1645-1656. PubMed ID: 36941816
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and mucormycosis superinfection: the perfect storm.
Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
[TBL] [Abstract][Full Text] [Related]
10. COVID-19-associated mucormycosis in India: Why such an outbreak?
Pasquier G
J Mycol Med; 2023 Aug; 33(3):101393. PubMed ID: 37182234
[TBL] [Abstract][Full Text] [Related]
11. Long-term Outcome of Coronavirus Disease-associated Mucormycosis: 1-year Follow-up Study from India.
Agrawal P; Singh AP; Chakotiya PS; Kumar V; Gautam A; Kumar D
J Assoc Physicians India; 2024 Jun; 72(6):44-48. PubMed ID: 38881134
[TBL] [Abstract][Full Text] [Related]
12. Mucormycosis: An opportunistic pathogen during COVID-19.
Mahalaxmi I; Jayaramayya K; Venkatesan D; Subramaniam MD; Renu K; Vijayakumar P; Narayanasamy A; Gopalakrishnan AV; Kumar NS; Sivaprakash P; Sambasiva Rao KRS; Vellingiri B
Environ Res; 2021 Oct; 201():111643. PubMed ID: 34237335
[TBL] [Abstract][Full Text] [Related]
13. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
Singh AK; Singh R; Joshi SR; Misra A
Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
[TBL] [Abstract][Full Text] [Related]
14. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum.
Sharma S; Grover M; Bhargava S; Samdani S; Kataria T
J Laryngol Otol; 2021 May; 135(5):442-447. PubMed ID: 33827722
[TBL] [Abstract][Full Text] [Related]
15. Rampant Increase in Cases of Mucormycosis in India and Pakistan: A Serious Cause for Concern during the Ongoing COVID-19 Pandemic.
Ghazi BK; Rackimuthu S; Wara UU; Mohan A; Khawaja UA; Ahmad S; Ahmad S; Hasan MM; Dos Santos Costa AC; Ahmad S; Essar MY
Am J Trop Med Hyg; 2021 Aug; 105(5):1144-1147. PubMed ID: 34460426
[TBL] [Abstract][Full Text] [Related]
16. Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): a clinical and diagnostic perspective from India.
Singh K; Kumar S; Shastri S; Sudershan A; Mansotra V
Immunogenetics; 2022 Apr; 74(2):197-206. PubMed ID: 34596728
[TBL] [Abstract][Full Text] [Related]
17. Outbreak of Mucormycosis in Coronavirus Disease Patients, Pune, India.
Joshi S; Telang R; Tambe M; Havaldar R; Sane M; Shaikh A; Roy C; Yathati K; Sonawale S; Borkar R; Magar R; Bhitkar H; Shitole S; Nakate L; Kudrimoti J; Mave V
Emerg Infect Dis; 2022 Jan; 28(1):1-8. PubMed ID: 34586055
[TBL] [Abstract][Full Text] [Related]
18. [Mucormycosis in the time of COVID-19: risks and challenges].
Seidel D; Sal E; Nacov JA; Cornely OA; Kurzai O
Dtsch Med Wochenschr; 2024 May; 149(10):569-578. PubMed ID: 38657596
[TBL] [Abstract][Full Text] [Related]
19. COVID-19-associated-mucormycosis: possible role of free iron uptake and immunosuppression.
Tabassum T; Araf Y; Moin AT; Rahaman TI; Hosen MJ
Mol Biol Rep; 2022 Jan; 49(1):747-754. PubMed ID: 34709573
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 associated mucormycosis (CAM) in India: a formidable challenge.
Rao VUS; Arakeri G; Madikeri G; Shah A; Oeppen RS; Brennan PA
Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1095-1098. PubMed ID: 34507870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
